Cargando…
How metformin affects various malignancies by means of microRNAs: a brief review
Metformin known as the first-line orally prescribed drug for lowering blood glucose in type II diabetes (T2DM) has recently found various therapeutic applications including in cancer. Metformin has been studied for its influences in prevention and treatment of cancer through multiple mechanisms such...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045276/ https://www.ncbi.nlm.nih.gov/pubmed/33849540 http://dx.doi.org/10.1186/s12935-021-01921-z |